000			01296 a2200397 4500
005			20250513101714.0
264		0	_c19961115
008			199611s 0 0 eng d
022			_a0039-2499
024	7		_a10.1161/01.str.27.10.1731 _2doi
040			_aNLM _beng _cNLM
100	1		_aDulli, D A
245	0	0	_aCerebral venous thrombosis and activated protein C resistance. _h[electronic resource]
260			_bStroke _cOct 1996
300			_a1731-3 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdult
650	0	4	_aAnticoagulants _xtherapeutic use
650	0	4	_aCerebral Veins
650	0	4	_aContraceptives, Oral _xadverse effects
650	0	4	_aDrug Resistance
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aIntracranial Embolism and Thrombosis _xdrug therapy
650	0	4	_aPartial Thromboplastin Time
650	0	4	_aProtein C _xanalysis
650	0	4	_aProtein S _xanalysis
650	0	4	_aRisk Factors
650	0	4	_aSinus Thrombosis, Intracranial _xdrug therapy
650	0	4	_aWarfarin _xtherapeutic use
700	1		_aLuzzio, C C
700	1		_aWilliams, E C
700	1		_aSchutta, H S
773	0		_tStroke _gvol. 27 _gno. 10 _gp. 1731-3
856	4	0	_uhttps://doi.org/10.1161/01.str.27.10.1731 _zAvailable from publisher's website
999			_c8835506 _d8835506